Skip to product information
1 of 1

Omnis Health Embrace® Talk Blood Glucose Test Strips APX03AB0304

Omnis Health Embrace® Talk Blood Glucose Test Strips APX03AB0304

Regular price $32.99 USD
Regular price $65.99 USD Sale price $32.99 USD
Sale Sold out
Shipping calculated at checkout.
Package
Quantity
Features & Benefits
  • For use with Embrace Talking Meter

The full picture

Everything Vyvata knows about this product — the score, the evidence, the FAQ, and where else to find shopper reviews. No hidden data. Every vendor is scored on the same published rubric — no brand can pay for placement. Read the rubric →

58/100
Standard

Six-dimension breakdown

Evidence
60
Formulation
55
Manufacturing
62
Safety
70
Transparency
55
Sustainability
40

Why this scored 58/100

Consumer glucose test strips paired to Embrace Talk meter (a voice-output BGM designed for visually-impaired users). Real accessibility use case but the underlying meter is a budget FDA-cleared BGM, less accurate than premium meters. Strips only, no meter included.

Last scored: Full rubric →

Evidence & sources

The Vyvata score's Evidence dimension measures the quality of published RCT support for a product's active ingredients at the label dose. Our source hierarchy: double-blind RCTs in MEDLINE-indexed journals > single-blind RCTs > open-label trials > observational studies > mechanism papers > N=1 case studies (anecdotes). Predatory journals and manufacturer-authored studies without independent replication are weighted down.

Product-specific evidence citations for this item are embedded in the analysis text on the "Analysis" tab. For the full framework and evidence hierarchy, see the methodology page.

How to read the Evidence dimension

  • 80–100: Multiple double-blind RCTs in indexed journals directly testing this product OR the exact ingredients at the exact dose.
  • 60–79: Single double-blind RCT + supporting ingredient literature at the studied dose.
  • 40–59: Open-label trials + ingredient literature; no product-specific double-blind evidence.
  • 20–39: Ingredient literature only; no product-specific trials or trials in predatory venues.
  • 0–19: No credible evidence base or unverifiable claims.

Frequently asked questions

Auto-generated from Vyvata's scoring data for this product. For general questions about the store (shipping, returns, wholesale), see the site FAQ.

What is Omnis Health Embrace® Talk Blood Glucose Test Strips APX03AB0304?

Omnis Health Embrace® Talk Blood Glucose Test Strips APX03AB0304 is a product from Medsitis, categorized under Glucose & diabetes self-monitoring in the Diagnostics & Testing vertical. It is scored on the Vyvata Scoring Framework — an independent 6-dimension rubric applied uniformly to every product Vyvata lists.

How does Omnis Health Embrace® Talk Blood Glucose Test Strips APX03AB0304 score on the Vyvata rubric?

58/100 overall — Standard tier (50–69 band). Per-dimension breakdown: Safety 70, Manufacturing 62, Evidence 60, Formulation 55, Transparency 55, Sustainability 40. Scored as of 2026-07-31.

Why did Omnis Health Embrace® Talk Blood Glucose Test Strips APX03AB0304 score in the Standard tier?

Consumer glucose test strips paired to Embrace Talk meter (a voice-output BGM designed for visually-impaired users). Real accessibility use case but the underlying meter is a budget FDA-cleared BGM, less accurate than premium meters. Strips only, no meter included.

What are the strongest and weakest aspects of this product?

Strongest: Safety at 70/100 (adverse-event profile, interaction risk, and dose ceiling) and Manufacturing at 62/100 (third-party testing, GMP compliance, and facility audit status). Weakest: Transparency at 55/100 (dose disclosure vs proprietary blends, and honesty of marketing claims) and Sustainability at 40/100 (sourcing practices, packaging, and corporate practice). All six dimensions feed the overall Vyvata score; a weakness on any one dimension pulls the overall down proportionally.

Is Omnis Health Embrace® Talk Blood Glucose Test Strips APX03AB0304 third-party tested?

No third-party certifications (NSF, USP, ConsumerLab, or equivalent) were on record at the time of scoring. This affects the Manufacturing dimension score. The manufacturer may test internally or have obtained certification more recently — check the current product label for the most up-to-date information.

Are there higher-scoring alternatives to Omnis Health Embrace® Talk Blood Glucose Test Strips APX03AB0304?

The top-ranked glucose & diabetes self-monitoring product in the Vyvata catalog is currently A1CNow® Self Check HbA1c Diabetes Management HbA1c Test Kit 3070 at 71/100. See the full ranked list of 5 scored products in this subcategory at https://vyvata.com/pages/best-glucose-and-diabetes-self-monitoring-ranked.

What does the Vyvata score mean?

The Vyvata Scoring Framework rates every listed product 0–100 across six dimensions: Evidence, Formulation, Manufacturing, Safety, Transparency, and Sustainability. Tier bands: Elite 85–100 (top-tier evidence + formulation + manufacturing), Verified 70–84 (strong on most dimensions), Standard 50–69 (solid but with weaknesses called out), Rejected 0–49 (specific failures documented). Rejected products remain listed with reasons. Full methodology at https://vyvata.com/pages/methodology.

Where can I read customer reviews for Omnis Health Embrace® Talk Blood Glucose Test Strips APX03AB0304?

Customer reviews

Reviews on other platforms

The Vyvata score measures product integrity against a published rubric, not customer sentiment. Vyvata does not aggregate, republish, or license third-party reviews — the links below open search pages on their respective platforms.

All the data we have on this product

Every VSF-related metafield surfaced verbatim. Nothing hidden. If you spot data that looks wrong, let us know.

VSF score
58 / 100
Tier
Standard
Category
Diagnostics testing
Subcategory
glucose diabetes monitoring
Last scored
Third-party certifications
None on record at time of scoring
Vendor
Medsitis
Product type
Glucose Meter Test Strips
Tags
Medsitis, Shopify Collective

Every score is set from the published rubric, audit-logged, and rescored whenever new evidence emerges (published trials, updated labels, third-party testing releases). Every vendor is scored on the same criteria — no pay-to-play. See our editorial-independence disclosure for the full policy, including brands with an editorial relationship to this site.

View full details